148 related articles for article (PubMed ID: 31292507)
1. Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4.
Kim S; Ko D; Lee Y; Jang S; Lee Y; Lee IY; Kim S
Sci Rep; 2019 Jul; 9(1):10003. PubMed ID: 31292507
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors.
Kang S; Min HJ; Kang MS; Jung MG; Kim S
Bioorg Med Chem Lett; 2013 Mar; 23(6):1748-51. PubMed ID: 23414802
[TBL] [Abstract][Full Text] [Related]
3. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.
Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS4 promotes invasiveness of human gastric cancer cells through activation of NF-κB/MMP-9 signaling.
Jin J; Shen X; Chen L; Bao LW; Zhu LM
Biomed Pharmacother; 2016 Feb; 77():30-6. PubMed ID: 26796262
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
[TBL] [Abstract][Full Text] [Related]
7. TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.
Huang A; Zhou H; Zhao H; Quan Y; Feng B; Zheng M
Cancer Biol Ther; 2014 Mar; 15(3):297-304. PubMed ID: 24335200
[TBL] [Abstract][Full Text] [Related]
8. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TMPRSS4 mediated epithelial-mesenchymal transition is critically involved in antimetastatic effect of melatonin in colorectal cancers.
Oh BS; Im E; Lee HJ; Sim DY; Park JE; Park WY; Park Y; Koo J; Pak JN; Kim DH; Shim BS; Kim SH
Phytother Res; 2021 Aug; 35(8):4538-4546. PubMed ID: 34114707
[TBL] [Abstract][Full Text] [Related]
10. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
[TBL] [Abstract][Full Text] [Related]
11. TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration.
Jianwei Z; Qi L; Quanquan X; Tianen W; Qingwei W
Pathol Oncol Res; 2018 Apr; 24(2):251-257. PubMed ID: 28466252
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology.
Larzabal L; Nguewa PA; Pio R; Blanco D; Sanchez B; Rodríguez MJ; Pajares MJ; Catena R; Montuenga LM; Calvo A
Br J Cancer; 2011 Nov; 105(10):1608-14. PubMed ID: 22067904
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancer.
Li XM; Liu WL; Chen X; Wang YW; Shi DB; Zhang H; Ma RR; Liu HT; Guo XY; Hou F; Li M; Gao P
Int J Mol Med; 2017 Apr; 39(4):927-935. PubMed ID: 28259959
[TBL] [Abstract][Full Text] [Related]
14. The upregulation of TMPRSS4, partly ascribed to the downregulation of miR‑125a‑5p, promotes the growth of human lung adenocarcinoma via the NF‑κB signaling pathway.
Fan X; Liang Y; Liu Y; Bai Y; Yang C; Xu S
Int J Oncol; 2018 Jul; 53(1):148-158. PubMed ID: 29750426
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of TMPRSS4 in prostate cancer.
Shi G; Yang X; Dai B; Zhang H; Shen Y; Zhu Y; Zhu Y; Xiao W; Ma C; Wen L; Qin X; Cao D; Ye D
Int J Clin Exp Pathol; 2014; 7(11):8053-8. PubMed ID: 25550850
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of soluble EP2 receptor on ovarian tumor growth in nude mice and utility of TMPRSS4 as a combinatorial molecular target.
Takahashi T; Uehara H; Izumi K
Int J Oncol; 2013 Aug; 43(2):416-24. PubMed ID: 23708855
[TBL] [Abstract][Full Text] [Related]
17. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.
Kim S; Kang HY; Nam EH; Choi MS; Zhao XF; Hong CS; Lee JW; Lee JH; Park YK
Carcinogenesis; 2010 Apr; 31(4):597-606. PubMed ID: 20118200
[TBL] [Abstract][Full Text] [Related]
18. Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.
Exposito F; Villalba M; Redrado M; de Aberasturi AL; Cirauqui C; Redin E; Guruceaga E; de Andrea C; Vicent S; Ajona D; Montuenga LM; Pio R; Calvo A
Cancer Lett; 2019 Jul; 453():21-33. PubMed ID: 30905815
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS4 induces cancer cell invasion through pro-uPA processing.
Min HJ; Lee MK; Lee JW; Kim S
Biochem Biophys Res Commun; 2014 Mar; 446(1):1-7. PubMed ID: 24434139
[TBL] [Abstract][Full Text] [Related]
20. Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma.
Hamamoto J; Soejima K; Naoki K; Yasuda H; Hayashi Y; Yoda S; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Arai D; Ishioka K; Ohgino K; Betsuyaku T
Cancer Sci; 2015 Jan; 106(1):34-42. PubMed ID: 25414083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
